Literature DB >> 3261646

Delineation of impaired regional myocardial perfusion by positron emission tomography with H2(15)O.

M N Walsh1, S R Bergmann, R L Steele, J L Kenzora, M M Ter-Pogossian, B E Sobel, E M Geltman.   

Abstract

Positron emission tomography with 15O-labeled water (H2(15)O) can be used to delineate abnormal regional myocardial blood flow in experimental animals. To determine the feasibility of this method in humans, we studied 33 subjects (9 normal volunteers and 24 patients with angiographically documented coronary artery disease) at rest and after myocardial hyperemia induced with intravenous infusion of dipyridamole. At rest, the myocardial region demonstrating the lowest relative H2(15)O activity exhibited 71 +/- 8% of activity in the region with peak activity in control subjects and 62 +/- 17% in patients (p = NS). After the dipyridamole infusion, differences between the two groups were accentuated. In control subjects, activity in the region with lowest relative radioactivity averaged 77 +/- 5% of that in the region with peak activity. In patients, it averaged 55 +/- 22% of activity in the region with peak activity (p less than 0.01). Results in patients with ischemia with or without a history of remote myocardial infarction were not significantly different. In 22 of the 24 patients, the region with lowest relative perfusion corresponded anatomically to the region of myocardium distal to a stenosis. Thus, delineation of regional myocardial perfusion in patients with coronary artery disease is possible with positron emission tomography and H2(15)O. Further studies will be necessary to prospectively determine sensitivity and specificity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261646     DOI: 10.1161/01.cir.78.3.612

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

Review 1.  Positron emission tomography in paediatric cardiology.

Authors:  R M Quinlivan; R O Robinson; M N Maisey
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

Review 2.  The perfusable tissue index: a marker of myocardial viability.

Authors:  Paul Knaapen; Ronald Boellaard; Marco J W Götte; Arno P van der Weerdt; Cees A Visser; Adriaan A Lammertsma; Frans C Visser
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

Review 3.  Cardiology.

Authors:  L D Smith; D J Coltart
Journal:  Postgrad Med J       Date:  1990-04       Impact factor: 2.401

4.  Diagnosis and prognosis of coronary artery disease: PET is superior to SPECT: Pro.

Authors:  Rob S B Beanlands; George Youssef
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

Review 5.  Coronary vasomotor function assessed by positron emission tomography.

Authors:  Nagara Tamaki; Keiichiro Yoshinaga; Masanao Naya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-24       Impact factor: 9.236

Review 6.  Nuclear medicine to image applied pathophysiology: evaluation of reserves by emission computerized tomography.

Authors:  U Buell; H Schicha
Journal:  Eur J Nucl Med       Date:  1990

Review 7.  Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission.

Authors:  A Syrota; P Jehenson
Journal:  Eur J Nucl Med       Date:  1991

8.  Heterogeneity of regional nitrogen 13-labeled ammonia tracer distribution in the normal human heart: comparison with rubidium 82 and copper 62-labeled PTSM.

Authors:  R S Beanlands; O Muzik; G D Hutchins; E R Wolfe; M Schwaiger
Journal:  J Nucl Cardiol       Date:  1994 May-Jun       Impact factor: 5.952

9.  Role of myocardial perfusion single photon emission computed tomography in pediatric cardiology practice.

Authors:  P Shanmuga Sundaram; S Padma
Journal:  Ann Pediatr Cardiol       Date:  2009-07

Review 10.  Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas.

Authors:  Francesco Ceci; Andrei Iagaru; R Laudicella; N Quartuccio; G Argiroffi; P Alongi; L Baratto; E Califaretti; V Frantellizzi; G De Vincentis; A Del Sole; L Evangelista; S Baldari; S Bisdas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-13       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.